paper-with-me

Papers

Accurate Clinical Toxicity Prediction using Multi-task Deep Neural Nets and Contrastive Molecular Explanations

2022-04-13 · Bhanushee Sharma, Vijil Chenthamarakshan, Amit Dhurandhar, Shiranee Pereira, James A. Hendler, Jonathan S. Dordick, Payel Das

Explainable ML for molecular toxicity prediction is a promising approach for efficient drug development and chemical safety. A predictive ML model of toxicity can reduce experimental cost and time while mitigating ethical concerns by significantly reducing animal and clinical testing. Herein, we use a deep learning framework for simultaneously modeling in vitro, in vivo, and clinical toxicity data. Two different molecular input representations are used: Morgan fingerprints and pre-training SMILES embeddings. A multi-task deep learning model accurately predicts toxicity for all endpoints, including clinical, as indicated by AUROC and balanced accuracy. In particular, SMILES embeddings as input to the multi-task model improved clinical toxicity predictions compared to existing models in MoleculeNet benchmark. Additionally, our multi-task approach is comprehensive in the sense that it is comparable to state-of-the-art approaches for specific endpoints in in vitro, in vivo and clinical platforms. Through both the multi-task model and transfer learning, we were able to indicate the minimal need of in vivo data for clinical toxicity predictions. To provide confidence and explain the model's predictions, we adapt a post-hoc contrastive explanation method that returns pertinent positive and pertinent negative features, which correspond well to known mutagenic and reactive toxicophores, such as unsubstituted bonded heteroatoms, aromatic amines, and Michael receptors. Furthermore, toxicophore recovery by pertinent feature analysis captures more of the in vitro (53%) and in vivo (56%), rather than of the clinical (8%), endpoints, and indeed uncovers a preference in known toxicophore data towards in vitro and in vivo experimental data. To our knowledge, this is the first contrastive explanation, using both present and absent substructures, for predictions of clinical and in vivo molecular toxicity.

📄 PDF Abstract BibTeX arXiv:2204.06614

Code (1)

IBM/Contrastive-Explanation-Method 공식 구현 tf

Tasks

Transfer Learning

Similar Papers 제목 키워드 기반

EchoRisk: A Multicentre Echocardiography Dataset and Benchmark for Cardio-Oncology

2026-07-01 · Grigorios Kalliatakis, Georgia Karanasiou, Georgios Manikis, Manolis Tsiknakis 외 arxiv

Therapy-induced cardiotoxicity is the leading non-oncological cause of treatment interruption in breast cancer patients, yet early, automated risk stratification from routine cardiac imaging remains an unsolved problem. …

Multimodal AI predicts clinical outcomes of drug combinations from preclinical data

2025-03-04 · Yepeng Huang, Xiaorui Su, Varun Ullanat, Ivy Liang 외

Predicting clinical outcomes from preclinical data is essential for identifying safe and effective drug combinations. Current models rely on structural or target-based features to identify high-efficacy, low-toxicity dru…

Large Language Model

LipoAgent: Coordinating Fine-Tuned LLM Agents for Safer Lipid Design

2026-05-24 · Leshu Li, An Lu, Haiyu Wang, Zhibin Feng 외 arxiv

Lipid nanoparticles (LNPs) are among the most clinically mature platforms for nucleic acid delivery, yet designing lipids that are both effective and biologically safe remains a major bottleneck. In practical screening, …

Bio AI Agent: A Multi-Agent Artificial Intelligence System for Autonomous CAR-T Cell Therapy Development with Integrated Target Discovery, Toxicity Prediction, and Rational Molecular Design

2025-11-11 · Yi Ni, Liwei Zhu, Shuai Li arxiv

Chimeric antigen receptor T-cell (CAR-T) therapy represents a paradigm shift in cancer treatment, yet development timelines of 8-12 years and clinical attrition rates exceeding 40-60% highlight critical inefficiencies in…

Combining human cell line transcriptome analysis and Bayesian inference to build trustworthy machine learning models for prediction of animal toxicity in drug development

2019-11-12

Biomedical data, particularly in the field of genomics, has characteristics which make it challenging for machine learning applications - it can be sparse, high dimensional and noisy. Biomedical applications also present…

Bayesian InferenceDrug DiscoveryGaussian ProcessesModel Selection